1. Home
  2. PASW vs LGVN Comparison

PASW vs LGVN Comparison

Compare PASW & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PASW
  • LGVN
  • Stock Information
  • Founded
  • PASW 2021
  • LGVN 2014
  • Country
  • PASW Hong Kong
  • LGVN United States
  • Employees
  • PASW N/A
  • LGVN N/A
  • Industry
  • PASW Apparel
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • PASW Consumer Discretionary
  • LGVN Health Care
  • Exchange
  • PASW Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • PASW 15.9M
  • LGVN 17.6M
  • IPO Year
  • PASW N/A
  • LGVN 2021
  • Fundamental
  • Price
  • PASW $0.52
  • LGVN $0.63
  • Analyst Decision
  • PASW
  • LGVN Strong Buy
  • Analyst Count
  • PASW 0
  • LGVN 2
  • Target Price
  • PASW N/A
  • LGVN $6.50
  • AVG Volume (30 Days)
  • PASW 48.9K
  • LGVN 388.1K
  • Earning Date
  • PASW 01-12-2026
  • LGVN 11-04-2025
  • Dividend Yield
  • PASW N/A
  • LGVN N/A
  • EPS Growth
  • PASW N/A
  • LGVN N/A
  • EPS
  • PASW N/A
  • LGVN N/A
  • Revenue
  • PASW $8,286,193.00
  • LGVN $1,437,000.00
  • Revenue This Year
  • PASW N/A
  • LGVN N/A
  • Revenue Next Year
  • PASW N/A
  • LGVN N/A
  • P/E Ratio
  • PASW N/A
  • LGVN N/A
  • Revenue Growth
  • PASW N/A
  • LGVN N/A
  • 52 Week Low
  • PASW $0.51
  • LGVN $0.59
  • 52 Week High
  • PASW $5.40
  • LGVN $2.24
  • Technical
  • Relative Strength Index (RSI)
  • PASW N/A
  • LGVN 30.36
  • Support Level
  • PASW N/A
  • LGVN $0.59
  • Resistance Level
  • PASW N/A
  • LGVN $0.67
  • Average True Range (ATR)
  • PASW 0.00
  • LGVN 0.05
  • MACD
  • PASW 0.00
  • LGVN -0.01
  • Stochastic Oscillator
  • PASW 0.00
  • LGVN 16.06

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: